Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $453 | $312 | $244 | $234 |
| Short-Term Investments | $14 | $42 | $79 | $0 |
| Receivables | $83 | $74 | $55 | $35 |
| Inventory | $7 | $5 | $4 | $4 |
| Other Curr. Assets | $22 | $18 | $18 | $11 |
| Total Curr. Assets | $579 | $451 | $400 | $284 |
| Property Plant & Equip (Net) | $3 | $0 | $1 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $113 | $137 | $161 | $144 |
| Long-Term Investments | $109 | $72 | $23 | $0 |
| Tax Assets | $0 | $144 | $86 | $0 |
| Other NC Assets | $194 | $7 | $4 | $1 |
| Total NC Assets | $420 | $360 | $274 | $149 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $999 | $811 | $674 | $433 |
| Liabilities | – | – | – | – |
| Payables | $14 | $18 | $4 | $1 |
| Short-Term Debt | $18 | $15 | $2 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $144 | $131 | $73 | $49 |
| Total Curr. Liab. | $175 | $164 | $79 | $54 |
| LT Debt | $164 | $179 | $190 | $192 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $2 | $3 | $1 |
| Total NC Liab. | $165 | $181 | $192 | $193 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $0 | $0 | $4 |
| Total Liabilities | $340 | $344 | $271 | $247 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $2 | -$143 | -$272 | -$454 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $657 | $610 | $675 | $640 |
| Total Equity | $659 | $467 | $403 | $187 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $999 | $811 | $674 | $433 |
| Net Debt | -$272 | -$118 | -$52 | -$39 |